Jeff Feeney

Jeff Feeney is a seasoned healthcare professional with extensive experience in advisory roles and executive leadership across various organizations. Currently serving as a member of the Board of Advisors at Boyd Street Ventures and as an Enterprise Healthcare Advisor at The Concord Group, Feeney also holds the position of EVP, Enterprise Development at SafeBaby® and advises Aeris Surgical Technologies and Ethos Laboratories. Previous roles include Senior Advisor at RxRevu, Inc. and Xenex Disinfection Services, as well as Chief Customer Officer at HealthiPASS Inc., which was successfully sold in December 2020. With a strong background in healthcare administration and strategic development, Feeney has contributed to numerous initiatives focusing on patient engagement, clinical resource management, and organizational structure. Education includes advanced degrees from Saint Louis University, Saint Ambrose University, and the University of Notre Dame - Mendoza College of Business.